News related to Revlimid (Lenalidomide) and/or conditions it is approved for
REVLIMID approved by the European Commission for the treatment of adult patients with previously untreated multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.31]
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, has announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult...
Case study reveals therapy to reduce sarcoidosis symptoms in 5q-myelodysplastic syndrome
Source: Respiratory / Asthma News From Medical News Today [2015.08.05]
Use of lenalidomide in 5q-myelodysplastic syndrome provides new hope in sarcoidosis therapyA case study published in the August issue of the journal CHEST found lenalidomide treatments may have...
Immunotherapy agent benefits patients with drug-resistant multiple myeloma
Source: Immune System / Vaccines News From Medical News Today [2015.08.27]
In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments...
FDA approves Kyprolis (carfilzomib) for combination use In the treatment of patients with relapsed multiple myeloma
Source: Blood / Hematology News From Medical News Today [2015.07.27]
Amgen has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with...
T-cell receptor therapy achieves encouraging clinical responses in multiple myeloma
Source: Transplants / Organ Donations News From Medical News Today [2015.07.21]
NY-ESO T cell receptor therapy found to be safe, with no cytokine release syndrome casesResults from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own...
Source: MedicineNet cyclophosphamide Specialty [2015.04.30]
Title: Multiple Myeloma
Category: Symptoms and Signs
Created: 4/30/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM
Daratumumab Activity 'Impressive' in Refractory Myeloma
Source: Medscape Hematology-Oncology Headlines [2015.08.27]
The investigational anti-CD38 monoclonal antibody has demonstrated promising single-agent activity in patients with difficult-to-treat multiple myeloma.
Medscape Medical News
Scientists and NASA astronauts developing near real-time osteoporosis and bone cancer test
Source: Bones / Orthopedics News From Medical News Today [2015.08.18]
A new test offers the possibility of near real time monitoring of bone diseases, such as osteoporosis and multiple myeloma.